Skip to main content
Enter your ZIP code, city, or state:

Provider participates in ASPIRE Galderma rewards

    What to expect

    What to expect

    While your appointment may take longer, treatment typically takes less than an hour, and you will begin to see results immediately.

    Here are some helpful tips! You can also learn more in our FAQs.

    • Discuss your aesthetics goals with your injector to determine a treatment plan that is right for you. This is your time to get all your questions answered. Arriving early may help you better maximize your appointment time.
    • Typically, you can expect minimal-to-no required downtime, but prior to your appointment, it is generally recommended that you avoid consuming things that may increase bruising or bleeding at the injection site such as non-steroidal anti-inflammatory drugs (NSAIDs; eg, ibuprofen), alcoholic beverages, St. John’s wort, and high doses of vitamin E.
    • Talk to your injector about options for keeping you as comfortable as possible during treatment. These may include numbing methods such as topical creams, using a filler that contains lidocaine, and cold compresses.
    • Check your ASPIRE Rewards points balance, and redeem any rewards that can be applied toward payment for your treatment.

    Explore by
    treatment area

    Actual patient. Individual results may vary.

    Explore by treatment area

    Post-treatment

    Typically, you can expect minimal-to-no required downtime and can begin to see results immediately following treatment.

    Please explore our FAQs to learn more.

    Ask your injector for their aftercare instructions
    Continue using cold compresses to help reduce any swelling
    Remember to ask about any needed follow-up appointments
    Remember to have your treatment logged in ASPIRE Rewards so that you are earning points for future savings
    References
    1. Restylane Lyft. Instructions for Use. Galderma Laboratories, L.P., 2023.
    2. Restylane Contour. Instructions for Use. Galderma Laboratories, L.P., 2023.
    3. Restylane Defyne. Instructions for Use. Galderma Laboratories, L.P., 2023.
    4. Restylane Refyne. Instructions for Use. Galderma Laboratories, L.P., 2023.
    5. Restylane. Instructions for Use. Galderma Laboratories, L.P., 2023.
    6. Restylane Kysse. Instructions for Use. Galderma Laboratories, L.P., 2023.
    7. Restylane Silk. Instructions for Use. Galderma Laboratories, L.P., 2023.
    8. Restylane Eyelight. Instructions for Use. Galderma Laboratories, L.P., 2023.
    9. Nikolis A, Berros P, Enright KM, Cordoba M, Nguyen Q. A randomized, crossover-controlled evaluator-blinded trial evaluating cannula- vs needle-assisted hyaluronic acid injections for infraorbital deformities. Aesthet Surg J. 2022;42(3):285-297.
    10. Nikolis A, Chesnut C, Biesman B, et al. Expert recommendations on the use of hyaluronic acid filler for tear trough rejuvenation. J Drugs Dermatol. 2022;21(4):387-392.
    Important Safety Information

    The Restylane family of products are indicated for patients over the age of 21, and includes Restylane®, Restylane-L®, Restylane® Lyft with Lidocaine, Restylane® Silk, Restylane® Kysse, Restylane® Refyne, Restylane® Defyne, Restylane® Contour, and Restylane® Eyelight.

    Approved Uses

    Restylane® and Restylane-L® are for mid-to-deep injection into the facial tissue for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. Restylane® and Restylane-L® are also indicated for injection into the lips.

    Restylane® Lyft with Lidocaine is for deep implantation into the facial tissue for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds and for cheek augmentation and for the correction of age-related midface contour deficiencies. Restylane® Lyft with Lidocaine is also indicated for injection into the dorsal hand to correct volume loss.

    Restylane® Silk is for lip augmentation and for correction of perioral wrinkles.

    Restylane® Kysse is for lip augmentation and for correction of upper perioral wrinkles.

    Restylane® Refyne is for mid-to-deep injection into the facial tissue for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds.

    Restylane® Defyne is for mid-to-deep injection into the facial tissue for the correction of moderate to severe deep facial wrinkles and folds, such as nasolabial folds. Restylane® Defyne is also indicated for injection into the mid-to-deep dermis (subcutaneous and/or supraperiosteal) for augmentation of the chin region to improve the chin profile in patients with mild to moderate chin retrusion.

    Restylane® Contour is for cheek augmentation and for the correction of midface contour deficiencies.

    Restylane® Eyelight is for the improvement of infraorbital hollowing.

    Do not use if you have severe allergies with a history of severe reactions (anaphylaxis), are allergic to lidocaine or gram-positive bacterial proteins used to make hyaluronic acid, prone to bleeding, or have a bleeding disorder. The safety of use while pregnant or breastfeeding has not been studied. Tell your doctor if you have a history of scarring or pigmentation disorders as these side effects can occur with hyaluronic acid fillers. Tell your doctor if you are planning other cosmetic treatments (i.e., lasers and chemical peels) as there is a possible risk of inflammation at the injection site.

    Tell your doctor if you’re taking medications that lower your body’s immune response or affect bleeding, such as aspirin or warfarin, as these medications may increase the risk of bruising or bleeding at the gel injection site. Using these products on gel injection sites with skin sores, pimples, rashes, hives, cysts, or infections should be postponed until healing is complete.

    The most common side effects are swelling, redness, pain, bruising, headache, tenderness, lump formation, itching at the injection site, and impaired hand function. Delayed-onset inflammation near the site of dermal filler injections is one of the known adverse events associated with dermal fillers, and cases have been reported to occur at the dermal filler treatment site following viral or bacterial illnesses or infections, vaccinations, or dental procedures. Typically, the reported inflammation was responsive to treatment or resolved on its own. Serious but rare side effects include delayed onset infections, recurrence of herpetic eruptions, and superficial necrosis at the injection site. The risk of unintentional injection into a blood vessel is small but can occur and could result in serious complications, which may be permanent including, vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring of the skin. As with all skin injection procedures, there is a risk of infection.

    To report a side effect with any Restylane® product, please call Galderma Laboratories, L.P. at 1-855-425-8722.

    To learn more about serious but rare side effects and full Important Safety Information, visit www.RestylaneUSA.com.

    US-RES-2300327